Lv31
254 积分 2026-02-25 加入
《胃癌生物标志物检测临床应用指南(2026版)》
1个月前
已完结
宫颈鳞癌中PD-L1不同抗体免疫组织化学染色的一致性分析
1个月前
已完结
Safety, Antitumor Activity, and Pharmacokinetics of Toripalimab, a Programmed Cell Death 1 Inhibitor, in Patients With Advanced Non–Small Cell Lung Cancer A Phase 1 Trial
1个月前
已完结
中华医学会肿瘤学分会肺癌临床诊疗指南(2026版)
1个月前
已完结
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breas tcancer:arandomized phase 3 trial
3个月前
已完结
Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancer
3个月前
已完结
A multiregional, randomized, controlled, open-label, phase 3 study of the anti-claudin18.2 (CLDN18.2) antibody-drug conjugate (ADC) arcotatug tavatecan (IBI343) ingastric or gastroesophageal junction adenocarcinoma (G/GEJA): Trial in progress
4个月前
已完结
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
8个月前
已完结